Chen et al. [31] reported that the homozygous CYP2C19*2/*2 genotype is an independent determinant of adverse vascular events in Chinese patients with CAD (HR = 5.191; 95% CI = 1.936–13.917; P = 0.001). The gene discussed is CYP2C19; the disease is coronary artery disorder.